Sign up to save your podcasts
Or
Share How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani
Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Virginia Kaklamani from the UTHealth San Antonio MD Anderson Cancer Center to discuss the latest advances in the treatment of triple negative breast cancer (TNBC) as we kick off 2025.
• The treatment paradigms for early-stage TNBC, including the role Sacituzumab and radiation therapy.
• Insights from the SABCS 2024 conference, focusing on the keynote 522 regimen and its implications for neoadjuvant treatment.
• The management of locally advanced and metastatic TNBC, including the use of immunotherapy and the importance of PD-L1 testing.
• Strategies for managing toxicities associated with treatments like sacituzumab and T-DXd.
Whether you're a healthcare professional or someone interested in the latest in oncology, this episode provides valuable insights into the evolving landscape of breast cancer treatment. Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!
Key Takeaways:
• Current standard of care for locally advanced TNBC.
• The significance of chemotherapy and immunotherapy in treatment plans.
• Managing toxicities in metastatic disease.
Stay tuned for more discussions on treatment algorithms, FDA approvals, and clinical pearls in oncology!
YouTube: https://youtu.be/GfROoYPVb_8
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
View all episodes
By Oncology Brothers
4.8
4040 ratings
Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Virginia Kaklamani from the UTHealth San Antonio MD Anderson Cancer Center to discuss the latest advances in the treatment of triple negative breast cancer (TNBC) as we kick off 2025.
• The treatment paradigms for early-stage TNBC, including the role Sacituzumab and radiation therapy.
• Insights from the SABCS 2024 conference, focusing on the keynote 522 regimen and its implications for neoadjuvant treatment.
• The management of locally advanced and metastatic TNBC, including the use of immunotherapy and the importance of PD-L1 testing.
• Strategies for managing toxicities associated with treatments like sacituzumab and T-DXd.
Whether you're a healthcare professional or someone interested in the latest in oncology, this episode provides valuable insights into the evolving landscape of breast cancer treatment. Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!
Key Takeaways:
• Current standard of care for locally advanced TNBC.
• The significance of chemotherapy and immunotherapy in treatment plans.
• Managing toxicities in metastatic disease.
Stay tuned for more discussions on treatment algorithms, FDA approvals, and clinical pearls in oncology!
YouTube: https://youtu.be/GfROoYPVb_8
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
322 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Research To Practice | Oncology Videos
116 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
288 Listeners
White Coat Investor Podcast
2,435 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
The ONS Podcast
199 Listeners
OncoPharm
184 Listeners
ASCO Guidelines
44 Listeners
OncLive® On Air
21 Listeners
Becker’s Healthcare Podcast
189 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Two Onc Docs
185 Listeners